fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Calcipotriol

All products: Limited Use (codes 191)

Dovonex · DIN 01976133 · 50 mcg/g · Oint

Limited Use, Reason for Use code 191 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 191 required
Write on scriptReason for Use code 191 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays: • ODB senior: $100/program-year deductible • Then up to $6.11 per prescription • Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Ontario Limited Use criteria, code 191
Reason for Use code 191 For the treatment of psoriasis in patients who have failed topical corticosteroids alone, or are intolerant to topical corticosteroids. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Dovonex · DIN 01976133 Manufacturer: Leo Pharma Inc.; listing date 1997-04-10 Health Canada: Marketed since 1992-12-31 · brand DOVONEX · ATC D05AX02 CALCIPOTRIOL · form Ointment · route Topical · ingredients CALCIPOTRIOL 50 MCG/G · company Leo pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Dovonex: Formulary list price $1.25 per unit (the source does not state the unit; exact figure $1.2489). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01976133)

Source record
DIN 01976133: Dovonex Raw flags: sec12=Y, sec3=Y Item: 843600044; group id 859; item number 2080; lccId 00119; manufacturer id LEO Source form: Oint; strength: 50mcg/g Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $1.2489; ministry $1.2489 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01976133 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13340
Shortage status: resolved shortage (ended November 1, 2022); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01976133
Shortage record checked October 6, 2026

Other products in the same Health Canada class (D05AX): coverage varies; not interchangeable

  • Calcitriol (Silkis): limited Use 191

Calcipotriol & betamethasone dipropionate

Form:

5 of 5 products shown

All strengths: General benefit; same patient cost rules

Shared coverage and patient cost rules
StatusGeneral benefit
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription

Dovobet · DIN 02244126 · 50 mcg/g & 0.5 mg/g · Oint

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
1 brand, same coverage
Dovobet · DIN 02244126 Manufacturer: Leo Pharma Inc.; listing date 2008-05-16 Health Canada: Marketed since 2001-11-29 · brand DOVOBET OINTMENT · ATC D05AX52 CALCIPOTRIOL, COMBINATIONS, D05AX52 CALCIPOTRIOL, COMBINATIONS · form Ointment · route Topical · ingredients CALCIPOTRIOL 50 MCG/G, BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G · company Leo pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02244126)

Source record
DIN 02244126: Dovobet Raw flags: sec3=Y Item: 840600151; group id 840; item number 2043; lccId None; manufacturer id LEO Source form: Oint; strength: 50mcg/g & 0.5mg/g Recorded listing: General benefit Source prices (unrounded): $2.1918; ministry $1.2545 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02244126 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=68084 Therapeutic Notes (formulary) Note: For use in patients with psoriasis who have failed 1st line topical steroids and Dovonex (calcipotriol) therapy.
Interchangeable products
Teva-Betamethasone/Calcipotriol · DIN 02427419 · $1.2545
Shortage status: resolved shortage (ended October 1, 2018); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02244126
Shortage record checked October 6, 2026

Teva-Betamethasone/Calcipotriol · DIN 02427419 · 50 mcg/g & 0.5 mg/g · Oint

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
1 brand, same coverage
Teva-Betamethasone/Calcipotriol · DIN 02427419 Manufacturer: Teva Canada Limited; listing date 2021-04-30 Health Canada: Marketed since 2020-08-07 · brand TEVA-BETAMETHASONE/ CALCIPOTRIOL · ATC D07XC01 BETAMETHASONE, D07XC01 BETAMETHASONE · form Ointment · route Topical · ingredients BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G, CALCIPOTRIOL 50 MCG/G · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Teva-Betamethasone/Calcipotriol: Formulary list price $1.25 per unit (the source does not state the unit; exact figure $1.2545). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02427419)

Source record
DIN 02427419: Teva-Betamethasone/Calcipotriol Raw flags: sec3=Y Item: 840600151; group id 840; item number 2043; lccId None; manufacturer id TEV Source form: Oint; strength: 50mcg/g & 0.5mg/g Recorded listing: General benefit Source prices (unrounded): $1.2545; ministry $1.2545 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02427419 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91194 Therapeutic Notes (formulary) Note: For use in patients with psoriasis who have failed 1st line topical steroids and Dovonex (calcipotriol) therapy.
Interchangeable products
Dovobet · DIN 02244126 · $1.2545
Shortage status: active shortage (reported October 8, 2025, last updated September 25, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02427419
Shortage record checked October 6, 2026

Enstilar · DIN 02457393 · 50 mcg/g & 0.5 mg/g · Top Aero Foam

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Enstilar · DIN 02457393 Manufacturer: Leo Pharma Inc.; listing date 2018-10-31 Health Canada: Marketed since 2016-11-11 · brand ENSTILAR · ATC D05AX52 CALCIPOTRIOL, COMBINATIONS, D05AX52 CALCIPOTRIOL, COMBINATIONS · form Aerosol (foam) · route Topical · ingredients CALCIPOTRIOL (CALCIPOTRIOL MONOHYDRATE) 50 MCG/G, BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G · company Leo pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Enstilar: Formulary list price $1.64 per unit (the source does not state the unit; exact figure $1.6412). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02457393)

Source record
DIN 02457393: Enstilar Raw flags: sec3=Y Item: 840600154; group id 840; item number 2044; lccId None; manufacturer id LEO Source form: Top Aero Foam; strength: 50mcg/g & 0.5mg/g Recorded listing: General benefit Source prices (unrounded): $1.6412; ministry $1.6412 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02457393 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94445 Therapeutic Notes (formulary) For the treatment of moderate to severe scalp psoriasis in patients who have failed first-line topical corticosteroid therapy. For the treatment of mild to moderate body psoriasis in patients who have failed first-line topical corticosteroid therapy and Dovonex (calcipotriol) therapy.
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02457393
Shortage record checked October 6, 2026

Dovobet Gel · DIN 02319012 · 50 mcg/g & 0.5 mg/g · Top Gel

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
1 brand, same coverage
Dovobet Gel · DIN 02319012 Manufacturer: Leo Pharma Inc.; listing date 2011-05-19 Health Canada: Marketed since 2012-10-12 · brand DOVOBET GEL · ATC D05AX52 CALCIPOTRIOL, COMBINATIONS, D05AX52 CALCIPOTRIOL, COMBINATIONS · form Gel · route Topical · ingredients CALCIPOTRIOL (CALCIPOTRIOL MONOHYDRATE) 50 MCG/G, BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G · company Leo pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02319012)

Source record
DIN 02319012: Dovobet Gel Raw flags: sec3=Y Item: 840600152; group id 840; item number 2045; lccId None; manufacturer id LEO Source form: Top Gel; strength: 50mcg/g & 0.5mg/g Recorded listing: General benefit Source prices (unrounded): $2.1867; ministry $1.3142 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02319012 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=80450 Therapeutic Notes (formulary) Notes: For the treatment of moderate to severe scalp psoriasis in patients who have failed first-line topical corticosteroid therapy. For the treatment of mild to moderate body psoriasis in patients who have failed first-line topical corticosteroid therapy and Dovonex (calcipotriol) therapy.
Interchangeable products
Taro-Calcipotriol / Betamethasone Gel · DIN 02525178 · $1.3142
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02319012
Shortage record checked October 6, 2026

Taro-Calcipotriol / Betamethasone Gel · DIN 02525178 · 50 mcg/g & 0.5 mg/g · Top Gel

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
1 brand, same coverage
Taro-Calcipotriol / Betamethasone Gel · DIN 02525178 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2022-06-30 Health Canada: Marketed since 2022-06-01 · brand TARO-CALCIPOTRIOL / BETAMETHASONE GEL · ATC D05AX52 CALCIPOTRIOL, COMBINATIONS, D05AX52 CALCIPOTRIOL, COMBINATIONS · form Gel · route Topical · ingredients BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5 MG/G, CALCIPOTRIOL (CALCIPOTRIOL MONOHYDRATE) 50 MCG/G · company Taro pharmaceuticals inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Taro-Calcipotriol / Betamethasone Gel: Formulary list price $1.31 per unit (the source does not state the unit; exact figure $1.3142). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02525178)

Source record
DIN 02525178: Taro-Calcipotriol / Betamethasone Gel Raw flags: sec3=Y Item: 840600152; group id 840; item number 2045; lccId None; manufacturer id TAR Source form: Top Gel; strength: 50mcg/g & 0.5mg/g Recorded listing: General benefit Source prices (unrounded): $1.3142; ministry $1.3142 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02525178 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101421 Therapeutic Notes (formulary) Notes: For the treatment of moderate to severe scalp psoriasis in patients who have failed first-line topical corticosteroid therapy. For the treatment of mild to moderate body psoriasis in patients who have failed first-line topical corticosteroid therapy and Dovonex (calcipotriol) therapy.
Interchangeable products
Dovobet Gel · DIN 02319012 · $1.3142
Shortage status: resolved shortage (ended February 20, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02525178
Shortage record checked October 6, 2026

Other products in the same Health Canada class (D05AX): coverage varies; not interchangeable

  • Calcitriol (Silkis): limited Use 191
Other drugs in the same formulary classes and how they are covered

Other drugs in the same formulary class (84:06 Anti-Inflammatory) and how they are covered

Matched class: 84:06 Anti-Inflammatory

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Covered without a code on the Ontario formulary: BECLOMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE IN A BASE CONTAINING PROPYLENE GLYCOL, BETAMETHASONE DIPROPIONATE IN PROPYLENE GLYCOL BASE, HALOBETASOL PROPIONATE, MOMETASONE FUROATE Some products covered without a code (check the product listing): AMCINONIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE VALERATE, CLOBETASOL PROPIONATE, DESONIDE, FLUOCINONIDE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE VALERATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE 0.1% IN ORABASE 84:06 Anti-Inflammatory

AMCINONIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.1% · Cr

BECLOMETHASONE DIPROPIONATE

· 2 products · General benefit · strengths: 0.025% · Cr, Oint

BETAMETHASONE DIPROPIONATE

· 6 products · General benefit (5), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (1) · strengths: 0.05% · Cr, Lot, Oint

BETAMETHASONE DIPROPIONATE IN A BASE CONTAINING PROPYLENE GLYCOL

· 2 products · General benefit · strengths: 0.05% · Oint

BETAMETHASONE DIPROPIONATE IN PROPYLENE GLYCOL BASE

· 2 products · General benefit · strengths: 0.05% · Cr

BETAMETHASONE VALERATE

· 19 products · Listed, not a benefit (7), General benefit (12) · strengths: 0.05%, 0.1% · Cr, Lot, Oint, Scalp Lot

CLOBETASOL PROPIONATE

· 20 products · General benefit (11), Off-Formulary Interchangeable, not an ODB benefit (9) · strengths: 0.05%, 0.05% w/w · Cr, Oint, Scalp Lot, Top Shampoo, Top Sol Sp

DESONIDE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.05% · Cr, Oint

FLUOCINONIDE

· 8 products · General benefit (4), Listed, not a benefit (4) · strengths: 0.05% · Cr, Emol Cr, Gel, Oint

HALOBETASOL PROPIONATE

· 1 products · General benefit · strengths: 0.01% w/w · Lot

HYDROCORTISONE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.5%, 1% · Oint

HYDROCORTISONE ACETATE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 1% · Cr Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:06 and 5 more
Full class listing Related classes: 84:04 Anti-Infectives, 84:28 Keratolytic Agents, 84:36 Miscellaneous Skin and Mucous Membrane Agents

Other drugs in the same formulary class (84:36 Miscellaneous Skin and Mucous Membrane Agents) and how they are covered

Matched class: 84:36 Miscellaneous Skin and Mucous Membrane Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Covered without a code on the Ontario formulary: ACITRETIN, AZELAIC ACID, FLUOROURACIL, ISOTRETINOIN, ZINC SULFATE Some products covered without a code (check the product listing): COLLAGENASE 84:36 Miscellaneous Skin and Mucous Membrane Agents

CALCITRIOL

· 1 products · Limited Use, codes 191 · strengths: 3mcg/g · Oint

ACITRETIN

· 6 products · General benefit · strengths: 10mg, 25mg · Cap

AZELAIC ACID

· 1 products · General benefit · strengths: 15% · Top Gel

COLLAGENASE

· 2 products · General benefit (1), Temporary benefit (1) · strengths: 250Unit/g · 30g Pk, Oint-30g Pk

FLUOROURACIL

· 1 products · General benefit · strengths: 5% · Cr

ISOTRETINOIN

· 8 products · General benefit · strengths: 10mg, 20mg, 30mg, 40mg · Cap

ZINC SULFATE

· 2 products · General benefit · strengths: 0.5%, 10mg · Oint, Sup

ALITRETINOIN

· 4 products · Listed, not a benefit (2), Limited Use, codes 442 (2) · strengths: 10mg, 30mg · Cap

BRODALUMAB

· 1 products · Limited Use, codes 553 · strengths: 210mg/1.5mL · Inj Sol-Pref Syr

IXEKIZUMAB

· 2 products · Limited Use, codes 526 · strengths: 80mg/mL · Inj Sol-Pref Autoinj, Inj Sol-Pref Syr

PIMECROLIMUS

· 1 products · Limited Use, codes 383 · strengths: 1% · Cr

RISANKIZUMAB

· 3 products · Limited Use, codes 574 · strengths: 75mg/0.83mL, 150mg/mL · Inj Sol-0.83mL Pref Syr (Preservative-Free), Inj Sol-Pref Pen (Preservative-Free), Inj Sol-Pref Syr (Preservative-Free) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:36 and 3 more
Full class listing Related classes: 84:04 Anti-Infectives, 84:06 Anti-Inflammatory, 84:28 Keratolytic Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: download failed: DPDUnavailable
What the Health Canada label says it is for
1. Indications DOVOBET (calcipotriol and betamethasone dipropionate) ointment is indicated for: • the topical treatment of psoriasis vulgaris for up to 4 weeks. 1.1. Pediatrics Pediatrics (< 18 years): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 1.2. Geriatrics Geriatrics (≥ 65 years): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use. https://pdf.hres.ca/dpd_pm/00085846.PDF PM date: 2026-08-21 Source product: DOVOBET OINTMENT; DIN 02244126; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Teva-Betamethasone/Calcipotriol · DIN 02427419 Shortage status: active shortage (reported 2025-10-08, last updated 2026-09-25); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02427419

Check this DIN again
Program rules and quotes
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules): ODB 65 and over (seniors path) Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗) Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗) Eligibility: Individual annual net income threshold Program year August 1, 2026 to July 31, 2027: $25,480 This applies to a senior who: does not have a spouse has a married spouse with whom they no longer live in a conjugal relationship has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗) Eligibility: Combined annual net income requirement Program year August 1, 2026 to July 31, 2027: $42,290 This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗) Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗) What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗) What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗) What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗) Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗) Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100. That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year). For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25. Use this chart below to see what the deductible will be in your first year:
Month you were bornAmount of first-year deductible
July$100.00
August$91.67
September$83.33
October$75.00
November$66.67
December$58.33
January$50.00
February$41.67
March$33.33
April$25.00
May$16.67
June$8.33

Ontario source · 2026-08-18